Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $1.2 million.

  • Angiodynamics' Capital Expenditures rose 300.69% to $1.2 million in Q4 2025 from the same period last year, while for Nov 2025 it was $4.0 million, marking a year-over-year increase of 3402.48%. This contributed to the annual value of $4.5 million for FY2025, which is 7728.36% up from last year.
  • Per Angiodynamics' latest filing, its Capital Expenditures stood at $1.2 million for Q4 2025, which was up 300.69% from $820000.0 recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' Capital Expenditures peaked at $4.5 million during Q3 2021, and registered a low of -$4.4 million during Q2 2022.
  • For the 5-year period, Angiodynamics' Capital Expenditures averaged around $955600.0, with its median value being $1.2 million (2022).
  • Per our database at Business Quant, Angiodynamics' Capital Expenditures plummeted by 80629.03% in 2022 and then skyrocketed by 18198.07% in 2025.
  • Over the past 5 years, Angiodynamics' Capital Expenditures (Quarter) stood at $2.7 million in 2021, then tumbled by 55.3% to $1.2 million in 2022, then changed by 0.0% to $1.2 million in 2023, then fell by 4.2% to $1.2 million in 2024, then rose by 3.01% to $1.2 million in 2025.
  • Its Capital Expenditures was $1.2 million in Q4 2025, compared to $820000.0 in Q3 2025 and $596000.0 in Q2 2025.